11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

 

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review
I

SABCS Update on HER2+ MBC: How Effective Is Margetuximab + Chemo After Prior Anti-HER2 Therapies? What Are the Available Management Options for 1L and Beyond?

By 11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review FEATURING Ingrid Mayer
By 11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review FEATURING Ingrid Mayer
99 views
February 23, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

06:40
Lilly Medical Affairs

Communicating the Risk of Recurrence for Patients With HR+, HER2- Ea…

Feat. J. O’Shaughnessy

Featured Video

11:11
Lilly Medical Affairs

Supporting Patients With Breast Cancer in the Clinic: Setting the Pa…

Feat. S. Dawood
Videos
34:39

Genomic/Molecular Profiling & Targeting Adaptive Resistance in BC: R…

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

G. Mills

122 views
45:55

SABCS Axilla Management Updates: Omitting SLND, cN- (SLN+ & Elderly …

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

A. Caudle

200 views
27:54

SABCS Updates on Adjuvant ET in ER+ BC: How Do Genomic Studies Guide…

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

B. Lim

371 views
06:43

SABCS Advanced ER+ BC Highlights: Outcomes With Exemestane+/-Entinos…

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

B. Lim

100 views
50:53

Fertility Preservation in Women With BC: Basic Principles & Science …

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

A. Delaney

120 views
08:57

SABCS ASCENT Trial Update on mTNBC: Is Sacituzumab Govitecan More Ef…

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

I. Mayer

111 views
08:07

Novel Therapeutics in Advanced HER2+ MBC

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

I. Mayer

42 views
10:21

ADCs in HER2+ MBC: Durable Antitumor Activity of T-DXd in a Pretreat…

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

I. Mayer

183 views
09:24

SABCS Update on HER2+ MBC: How Effective Is Margetuximab + Chemo Aft…

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

I. Mayer

99 views
14:16

SABCS Clinical Trial Data on IO in mTNBC: Do 1L Atezo or Pembro Adde…

11th Annual Midwest Regional San Antonio Breast Cancer Symposium Review

I. Mayer

27 views